126 related articles for article (PubMed ID: 19261089)
1. Transcriptome dissection of gastric cancer: identification of novel diagnostic and therapeutic targets from pathology specimens.
Yasui W; Oue N; Sentani K; Sakamoto N; Motoshita J
Pathol Int; 2009 Mar; 59(3):121-36. PubMed ID: 19261089
[TBL] [Abstract][Full Text] [Related]
2. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer.
Aung PP; Oue N; Mitani Y; Nakayama H; Yoshida K; Noguchi T; Bosserhoff AK; Yasui W
Oncogene; 2006 Apr; 25(17):2546-57. PubMed ID: 16331256
[TBL] [Abstract][Full Text] [Related]
3. [Molecular-pathological diagnosis of gastric cancer].
Yasui W
Gan To Kagaku Ryoho; 2005 Apr; 32(4):427-31. PubMed ID: 15853204
[TBL] [Abstract][Full Text] [Related]
4. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
Oue N; Mitani Y; Aung PP; Sakakura C; Takeshima Y; Kaneko M; Noguchi T; Nakayama H; Yasui W
J Pathol; 2005 Oct; 207(2):185-98. PubMed ID: 16086444
[TBL] [Abstract][Full Text] [Related]
5. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
[TBL] [Abstract][Full Text] [Related]
6. Gene expression analysis of early and advanced gastric cancers.
Vecchi M; Nuciforo P; Romagnoli S; Confalonieri S; Pellegrini C; Serio G; Quarto M; Capra M; Roviaro GC; Contessini Avesani E; Corsi C; Coggi G; Di Fiore PP; Bosari S
Oncogene; 2007 Jun; 26(29):4284-94. PubMed ID: 17297478
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary study of the association between human thrombospondin and gastric cancer].
Li YH; Yang WZ; Chen JZ; Hu ZQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1546-9. PubMed ID: 18819864
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
9. Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy.
Mitani Y; Oue N; Matsumura S; Yoshida K; Noguchi T; Ito M; Tanaka S; Kuniyasu H; Kamata N; Yasui W
Oncogene; 2007 Jun; 26(30):4383-93. PubMed ID: 17237819
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker.
Hayashi T; Matsubara A; Ohara S; Mita K; Hasegawa Y; Usui T; Arihiro K; Norimura S; Sentani K; Oue N; Yasui W
Oncol Rep; 2009 Jan; 21(1):95-100. PubMed ID: 19082448
[TBL] [Abstract][Full Text] [Related]
11. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications.
Yasui W; Oue N; Ito R; Kuraoka K; Nakayama H
Cancer Sci; 2004 May; 95(5):385-92. PubMed ID: 15132764
[TBL] [Abstract][Full Text] [Related]
12. Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer.
Hsu PI; Hsieh HL; Lee J; Lin LF; Chen HC; Lu PJ; Hsiao M
Ann Surg Oncol; 2009 Jun; 16(6):1686-94. PubMed ID: 19290488
[TBL] [Abstract][Full Text] [Related]
13. Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression.
Oue N; Aung PP; Mitani Y; Kuniyasu H; Nakayama H; Yasui W
Oncology; 2005; 69 Suppl 1():17-22. PubMed ID: 16210872
[TBL] [Abstract][Full Text] [Related]
14. Novel biomarker candidates for gastric cancer.
Yang S; Chung HC
Oncol Rep; 2008 Mar; 19(3):675-80. PubMed ID: 18288401
[TBL] [Abstract][Full Text] [Related]
15. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
[TBL] [Abstract][Full Text] [Related]
17. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic and molecular aspects of gastric cancer: clinical implications.
Panani AD
Cancer Lett; 2008 Aug; 266(2):99-115. PubMed ID: 18381231
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathology of gastric cancer: research and practice.
Yasui W; Sentani K; Sakamoto N; Anami K; Naito Y; Oue N
Pathol Res Pract; 2011 Oct; 207(10):608-12. PubMed ID: 22005013
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinases and gastric cancer.
Lin W; Kao HW; Robinson D; Kung HJ; Wu CW; Chen HC
Oncogene; 2000 Nov; 19(49):5680-9. PubMed ID: 11114748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
